Position in IQV
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$8,527
-$2,743 QoQ
Shares Held
50
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Frazier Financial Advisors, LLC holds $190,714 across 11 Diagnostics & Research names. IQV ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
127 | $62,424 | |
| 2 | DHR |
Danaher Corp /De/
|
199 | $37,730 | |
| 3 | DGX |
Quest Diagnostics Inc
|
166 | $32,532 | |
| 4 | LH |
Labcorp Holdings Inc.
|
100 | $26,681 | |
| 5 | WAT |
Waters Corp /De/
|
30 | $8,934 | |
| 6 | IQV |
Iqvia Holdings Inc.
This page
|
50 | $8,527 | |
| 7 | A |
Agilent Technologies, Inc.
|
59 | $6,724 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
10 | $5,618 |
All Filings in IQV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,527 | 50 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $11,270 | 50 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $9,497 | 50 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $7,879 | 50 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $8,815 | 50 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $9,825 | 50 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $11,848 | 50 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $10,572 | 50 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $12,644 | 50 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $11,569 | 50 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||